The rate and risk of secondary pelvic malignancies (SPM) in patients treated with definitive radiation for locally advanced rectal cancer.

Authors

Kathryn Tringale

Kathryn Ries Tringale

Memorial Sloan Kettering Cancer Center, New York, NY

Kathryn Ries Tringale , Lara Hilal , Abraham Jing-Ching Wu , Andrea Cercek , Marsha Reyngold , Paul Bernard Romesser , Emmanouil Pappou , Jessica Flynn , Zhigang Zhang , John Navilio , Sean Berry , Rona Yaeger , Philip Paty , Martin R. Weiser , Julio Garcia-Aguilar , Leonard B. Saltz , Christopher H Crane , Carla Hajj

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Symptoms and Survivorship

Track

Symptom Science and Palliative Care

Sub Track

Late and Long-Term Adverse Effects

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 12065)

DOI

10.1200/JCO.2021.39.15_suppl.12065

Abstract #

12065

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

Poster

2024 ASCO Gastrointestinal Cancers Symposium

Total neoadjuvant therapy (TnT) with FOLFOX followed by short course radiation in locally advanced rectal cancer: A phase II study.

Total neoadjuvant therapy (TnT) with FOLFOX followed by short course radiation in locally advanced rectal cancer: A phase II study.

First Author: Janice Zhao

First Author: Richard Francis Dunne